Efficacy of different neoadjuvant treatment regimens in BRCA-mutated triple negative breast cancer: a systematic review and meta-analysis

Abstract Purpose Triple negative breast cancer (TNBC) is an aggressive breast cancer strongly associated with BRCA mutation. Standard neoadjuvant chemotherapy remains the standard of care for early stage TNBC, the optimal chemotherapy regimen is still a matter of discussion. Other agents, such as po...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Olga Caramelo, Cristina Silva, Francisco Caramelo, Cristina Frutuoso, Leonor Pinto, Teresa Almeida-Santos
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2022-09-01
coleção:	Hereditary Cancer in Clinical Practice
Assuntos:	Triple negative breast cancer BRCA Neoadjuvant chemotherapy Cisplatin Carboplatin PARPi
Acesso em linha:	https://doi.org/10.1186/s13053-022-00242-0
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!